RGLGX | RWIEX | RGLGX / RWIEX | |
Total Expense Ratio | 0.45 | 0.76 | 59% |
Annual Report Gross Expense Ratio | 0.45 | 0.76 | 59% |
Fund Existence | 6 years | 23 years | - |
Gain YTD | 19.718 | 20.098 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.7B | 141B | 13% |
Annual Yield % from dividends | 1.07 | 1.38 | 77% |
Returns for 1 year | 16.13 | 10.89 | 148% |
Returns for 3 years | 70.90 | 67.15 | 106% |
Returns for 5 years | 65.27 | 50.87 | 128% |
Returns for 10 years | N/A | 77.39 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MFSV | 25.87 | 0.27 | +1.05% |
MFS Active Value ETF | |||
DWX | 42.97 | 0.28 | +0.66% |
SPDR® S&P® International Dividend ETF | |||
XT | 72.97 | 0.10 | +0.14% |
iShares Future Exponential Techs ETF | |||
IDNA | 24.61 | -0.18 | -0.72% |
iShares Genomics Immnlgy & Hlthcr ETF | |||
IWML | 23.04 | -0.21 | -0.90% |
ETRACS 2x Leveraged US Size Fctr TR ETN |